March 1992

The Efficacy and Limitations of Percutaneous Endoscopic Gastrostomy

Author Affiliations

From the Department of Surgery, University of California, San Francisco (Drs Jarnagin, Duh, Mulvihill, Ridge, Schrock, and Way), and the Surgical Service, Veterans Affairs Medical Center, San Francisco (Drs Duh, Ridge, and Way).

Arch Surg. 1992;127(3):261-264. doi:10.1001/archsurg.1992.01420030023003

• We analyzed 64 percutaneous endoscopic gastrostomy procedures performed by us between 1986 and 1990. Thirty patients had neurologic disease; 16 had head and neck cancers; eight had other malignancies; two had acquired immunodeficiency syndrome; and eight had other problems. Seven patients died within 30 days of complications (n=4) or the primary illness (n=3). Mean follow-up was 6 months; an additional patient died of aspiration and eight others died of their underlying illness. There were 19 complications (32%). Four wound complications occurred. Nine patients developed aspiration pneumonia within 3 days of the procedure, four of whom died in the hospital. Of the 24 patients with a history of aspiration, nine experienced aspiration during or after percutaneous endoscopic gastrostomy. Patients with a history of aspiration were more likely to have perioperative aspiration pneumonia, and patients who experienced aspiration were more likely to die.

(Arch Surg. 1992;127:261-264)